 <h1>Congratulations! 🎉 </h1>
    <p style="color:#637381;">All done! You’ve completed another milestone.</p>

To continue, enter your details to log in.

We’ve sent a 6‑digit code to #MAIL_ADDRESS#\nPlease check your inbox or spam folder and enter the code below to continue.

Verification code sent

Thank you for the payment. You can now access {collectionName} by simply clicking the button below.

Yes, you’ve successfully ordered! 🎉

Unlock This Exclusive Course

It seems that your email address is not currently on the authorized access list. Please ensure you are using the email address that was invited, or contact the content owner for assistance.

Verification Required for Access

Course Overview

What is this course about?

Who is this mini-course for?

The Reference Table (Attachment 1, verified)

Title: Three Lines, Three Different Questions

Identification thresholds (must structurally identify) — this module's focus

Slide 4: Practical Application (60 sec)

Title: Reading the Line Correctly, Every Time

Step-by-step actions:

Title: Friday's Release Meeting

10-Point Audit / Inspection Checklist

Quiz

Title: The Peak That Wasn't There Last Year

Part A: Quiz (5 scenario-based questions)

Risk indicators (warning signs):

AVOID ✗

DO ✓

Survey

Part B: Reflection

Part C: Top 5 Takeaways

Welcome to the definitive guide on Applying ICH Q3B(R2) Identification Thresholds for Degradation Products. In the highly regulated pharmaceutical industry, ensuring the safety and efficacy of chemically synthesized small-molecule drug products is paramount.

Welcome to the definitive guide on Applying ICH Q3B(R2) Identification Thresholds for Degradation Products. In the highly regulated pharmaceutical industry, ensuring the safety and efficacy of chemically synthesized small-molecule drug products is paramount. A critical component of this process is accurately identifying and managing degradation products that occur during stability testing. This comprehensive course is designed to demystify the ICH Q3B(R2) guidelines, providing you with the practical knowledge needed to confidently navigate identification thresholds. Throughout this course, we will explore the fundamental rationale behind dose-dependent thresholds, emphasizing cumulative patient exposure and Total Daily Intake (TDI). You will learn how to differentiate between degradation products and process impurities, and how to correctly apply maximum-daily-dose bands to determine exact identification thresholds. We will dive deep into real-world analytical scenarios, such as borderline stability results during lot release reviews, and equip you with a robust 10-point audit and inspection checklist to ensure your laboratory controls are always inspection-ready. Whether you are dealing with low-dose or high-dose product formulations, this course will teach you the correct sequential workflow to read the reference tables accurately every time. By the end of this training, you will have mastered the step-by-step actions required to document, justify, and technically evaluate unknown peaks, ensuring full compliance with global regulatory standards.

117. Applying ICH Q3B(R2) Identification Thresholds for Degradation Products

<div class="simple-box-wrapper">
    <div class="simple-box">
        <div class="column">
            <p>The management of degradation products during the lifecycle of chemically synthesized small-molecule drug products requires strict adherence to established regulatory standards. ICH Q3B(R2) provides a critical framework for evaluating these impurities, specifically distinguishing between degradation products that emerge during stability testing and process impurities originating from active pharmaceutical ingredient (API) synthesis. Understanding the fundamental rationale behind dose-dependent thresholds is essential for quality assurance and control professionals, as these thresholds prioritize cumulative patient exposure over mere concentration. This course delivers a comprehensive examination of these principles, ensuring that analytical and regulatory actions align with global expectations. It is important to note that the methodologies discussed herein are strictly applicable to small-molecule formulations and explicitly exclude biologics and biosimilars, which are governed by entirely separate regulatory guidelines.</p>

<p>Throughout this program, participants will engage with the practical application of the ICH Q3B(R2) reference tables, with a primary focus on identification thresholds. The curriculum systematically breaks down the sequential workflow required to derive maximum daily doses, select appropriate identification bands, and apply Total Daily Intake (TDI) limits. By analyzing real-world analytical scenarios—such as borderline stability results encountered during lot release reviews—professionals will develop the competency to make defensible, risk-based decisions regarding investigation escalation and specification updates. Furthermore, the course emphasizes inspection readiness by outlining a robust audit checklist designed to ensure chromatographic data integrity, validated specificity, and meticulously documented identification attempts. Ultimately, this training equips stability scientists, QC analysts, and regulatory affairs personnel with the precise methodologies needed to enforce Q3B(R2) standards effectively and maintain rigorous compliance.</p>
        </div>
    </div>
</div>
